enalapril
Clinically relevant reductions in supine systolic blood       pressure/DBP were observed with telmisartan (14.6/13.2 mmHg) and enalapril       (13.0/12.9 mmHg) monotherapy.
Clinically relevant  @PREDICAT$  in supine systolic blood       pressure/ @OBJECT$  were observed with telmisartan (14.6/13.2 mmHg) and  @SUBJECT$        (13.0/12.9 mmHg) monotherapy.